Compare ACCL & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACCL | BTMD |
|---|---|---|
| Founded | 2009 | 2012 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.3M | 39.0M |
| IPO Year | 2024 | 2021 |
| Metric | ACCL | BTMD |
|---|---|---|
| Price | $2.58 | $1.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $2.61 |
| AVG Volume (30 Days) | 54.6K | ★ 126.7K |
| Earning Date | 11-16-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 722.22 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $192,219,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.45 |
| P/E Ratio | $17.13 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.23 | $1.15 |
| 52 Week High | $5.00 | $3.26 |
| Indicator | ACCL | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 44.51 | 27.27 |
| Support Level | $2.42 | N/A |
| Resistance Level | $3.16 | $1.68 |
| Average True Range (ATR) | 0.16 | 0.07 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 20.31 | 6.19 |
Acco Group Holdings Ltd is a holding company. Through its Operating Subsidiaries, it is a multi-disciplinary, IT-driven corporate service provider with a presence in Hong Kong and Singapore. Under the Accolade brand, it specializes in offering corporate secretarial services and accounting services in Hong Kong, as well as intellectual properties (IP) registration services in Singapore. Leveraging developed IT solutions, It provides comprehensive, reliable and professional support to its clients, enabling them to focus on their core business activities while it manages and handles their corporate compliance needs. Its clientele ranges from individual clients, small and medium-sized enterprises to multinational corporations, reflecting its ability to cater to diverse business needs.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.